British Journal of Haematology · 1999 · 64 citations · 16 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsReproductive GeneticsGenetic Risk AssessmentGenetic Risk PredictionInborn Errors Of MetabolismMolecular Risk FactorsPregnancyRecurrent Pregnancy LossAllele FrequencyFetal Risk PredictionGestation PeriodMatched Control GroupMethylenetetrahydrofolate Reductase PolymorphismsPregnancy Loss RiskRecurrent Miscarriage RiskRecurrent Pregnancy Loss Pathology
We have investigated the potency of the C677T mutation in the methylene tetrahydrofolate reductase (MTHFR) gene as a genetic risk factor in women with a history of early (</=12 weeks gestation) and/or late (>12 weeks gestation) recurrent miscarriage (three or more consecutive pregnancy losses). Fifty-seven of the total 173 (32. 9%) patients were heterozygous for the MTHFR mutation, 14/173 (8.1%) were homozygous (allele frequency 0.25). The prevalence of the MTHFR mutation in these women did not differ significantly from that in the control group of parous women with uneventful pregnancies, where 30/67 (44.8%) were heterozygous and 6/67 (9.0%) homozygous for the mutation (allele frequency 0.31; odds ratio for homozygous T/T 0.90, 95% CI 0.30-2.4). There was no association between the trimester of pregnancy loss and MTHFR genotype. We conclude that the C677T MTHFR mutation is not a risk predictor in women with a history of early or late recurrent miscarriage.
16
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences · 1993 · 2K citations
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
Martin den Heijer, Ted Koster, Henk J. Blom et al. · New England Journal of Medicine · 1996 · 1.1K citations · Full text